KENNEDY CAPITAL MANAGEMENT LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,439,119
+82.8%
636,366
+110.2%
0.18%
+90.5%
Q2 2023$4,069,686
-60.1%
302,804
-84.9%
0.10%
-21.5%
Q1 2019$10,198,000
+158.8%
1,999,574
+91.8%
0.12%
+65.8%
Q3 2018$3,941,000
+19.9%
1,042,645
-1.1%
0.07%
+19.7%
Q2 2018$3,288,000
+68.4%
1,053,871
+29.1%
0.06%
+60.5%
Q1 2018$1,952,000
-44.0%
816,571
-8.4%
0.04%
-38.7%
Q4 2017$3,484,000
+53.5%
891,174
-1.0%
0.06%
+51.2%
Q3 2017$2,270,000
-10.5%
900,618
-1.9%
0.04%
-14.6%
Q2 2017$2,535,000
+464.6%
918,438
+298.5%
0.05%
+500.0%
Q1 2017$449,000
+83.3%
230,500
-1.1%
0.01%
+100.0%
Q4 2016$245,000
-7.5%
233,171
-4.1%
0.00%
-20.0%
Q3 2016$265,000
+50.6%
243,236
-1.8%
0.01%
+25.0%
Q2 2016$176,000
-38.5%
247,711
+1.3%
0.00%
-33.3%
Q1 2016$286,000
-53.0%
244,452
-1.5%
0.01%
-50.0%
Q4 2015$608,000
-18.6%
248,217
-0.3%
0.01%
-20.0%
Q3 2015$747,000249,0710.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders